| Mylan is engaged in the global development, licensing, manufacturing, marketing and distributing generic, branded generic, brand-name and over-the-counter pharmaceutical products for resale by others and active pharmaceutical (API) ingredients through three segments, North America, Europe and Rest of World. Co.'s API business is conducted through its subsidiary, Mylan Laboratories Limited. North America segment comprises operations in the U.S. and Canada. Europe segment encompasses operations across countries, including France, Italy, Germany, the U.K. and Spain. Rest of World segment reflects operations in countries outside of its North America and Europe segments. We show 44 historical shares outstanding datapoints in our coverage of MYL's shares outstanding history.|
Understanding the changing numbers of MYL shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MYL versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MYL by allowing them to research MYL shares outstanding history
as well as any other stock in our coverage universe.